Cargando…

Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions

Despite the key-role of the Prostate Imaging and Reporting and Data System (PI-RADS) in the diagnosis and characterization of prostate cancer (PCa), this system remains to be affected by several limitations, primarily associated with the interpretation of equivocal PI-RADS 3 lesions and with the deb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brancato, Valentina, Aiello, Marco, Basso, Luca, Monti, Serena, Palumbo, Luigi, Di Costanzo, Giuseppe, Salvatore, Marco, Ragozzino, Alfonso, Cavaliere, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804929/ https://www.ncbi.nlm.nih.gov/pubmed/33436929 http://dx.doi.org/10.1038/s41598-020-80749-5

Ejemplares similares

Assessment of DCE Utility for PCa Diagnosis Using PI-RADS v2.1: Effects on Diagnostic Accuracy and Reproducibility
por: Brancato, Valentina, et al.
Publicado: (2020)

Multiparametric MRI for Prostate Cancer Detection: New Insights into the Combined Use of a Radiomic Approach with Advanced Acquisition Protocol
por: Monti, Serena, et al.
Publicado: (2020)

Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
por: Osses, Daniël F., et al.
Publicado: (2020)

Standardization of Multiparametric Prostate MR Imaging Using PI-RADS
por: Bomers, Joyce G. R., et al.
Publicado: (2014)

Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters
por: Woźnicki, Piotr, et al.
Publicado: (2020)

MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?
por: Schoots, Ivo G.
Publicado: (2018)

Radiomics in PI-RADS 3 Multiparametric MRI for Prostate Cancer Identification: Literature Models Re-Implementation and Proposal of a Clinical–Radiological Model
por: Corsi, Andrea, et al.
Publicado: (2022)

The role of different PI-RADS versions in prostate multiparametric magnetic resonance tomography assessment
por: Aliukonis, Paulius, et al.
Publicado: (2017)

Comparison of PSA density and lesion volume strategies for selecting men with equivocal PI-RADS 3 lesions on bpMRI for biopsies
por: Kortenbach, Karen-Cecilie, et al.
Publicado: (2022)

MRI Based Radiomics Compared With the PI-RADS V2.1 in the Prediction of Clinically Significant Prostate Cancer: Biparametric vs Multiparametric MRI
por: Chen, Tong, et al.
Publicado: (2022)

Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer
por: Rudolph, Madhuri M., et al.
Publicado: (2020)

Improving the understanding of PI-RADS in practice: characters of PI-RADS 4 and 5 lesions with negative biopsy
por: Wang, Yu-Hao, et al.
Publicado: (2023)

Joint Cancer Segmentation and PI-RADS Classification on Multiparametric MRI Using MiniSegCaps Network
por: Jiang, Wenting, et al.
Publicado: (2023)

Use of Radiomics to Improve Diagnostic Performance of PI-RADS v2.1 in Prostate Cancer
por: Li, Mou, et al.
Publicado: (2021)

Textured-Based Deep Learning in Prostate Cancer Classification with 3T Multiparametric MRI: Comparison with PI-RADS-Based Classification
por: Liu, Yongkai, et al.
Publicado: (2021)

Comparison of the PI-RADS 2.1 scoring system to PI-RADS 2.0: Impact on diagnostic accuracy and inter-reader agreement
por: Hötker, Andreas M., et al.
Publicado: (2020)

Correlation between Intraprostatic PSMA Uptake and MRI PI-RADS of [(68)Ga]Ga-PSMA-11 PET/MRI in Patients with Prostate Cancer: Comparison of PI-RADS Version 2.0 and PI-RADS Version 2.1
por: Zhao, Jing, et al.
Publicado: (2020)

Towards the Definition of Radiomic Features and Clinical Indices to Enhance the Diagnosis of Clinically Significant Cancers in PI-RADS 4 and 5 Lesions
por: Bonaffini, Pietro Andrea, et al.
Publicado: (2023)

The multiparametric prostate resonance imaging with the prostate imaging-reporting and data system (PI-RADS): the state of art of prostate cancer diagnosis
Publicado: (2019)

Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate
por: Boschheidgen, M., et al.
Publicado: (2022)

Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic‐Based Model vs. PI‐RADS v2
por: Chen, Tong, et al.
Publicado: (2018)

Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions
por: Li, Tianping, et al.
Publicado: (2022)

Low cancer yield in PI-RADS 3 upgraded to 4 by dynamic contrast-enhanced MRI: is it time to reconsider scoring categorization?
por: Messina, Emanuele, et al.
Publicado: (2023)

The Impact of Adding Digital Breast Tomosynthesis to BI-RADS Categorization of Mammographically Equivocal Breast Lesions
por: Hassan, Rania Mostafa, et al.
Publicado: (2023)

Impact of PI-RADS v2 on indication of prostate biopsy
por: Rozas, George de Queiroz, et al.
Publicado: (2019)

Standards for MRI reporting—the evolution to PI-RADS v 2.0
por: Spektor, Michael, et al.
Publicado: (2017)

Diagnostic Performance of PI-RADS v2, Proposed Adjusted PI-RADS v2 and Biparametric Magnetic Resonance Imaging for Prostate Cancer Detection: A Preliminary Study
por: Cai, Guan-Hui, et al.
Publicado: (2021)

Transverse prostate maximum sectional area can predict clinically significant prostate cancer in PI-RADS 3 lesions at multiparametric magnetic resonance imaging
por: Gaudiano, Caterina, et al.
Publicado: (2023)

PI-RADS v2.1: What has changed and how to report
por: Scott, Robin, et al.
Publicado: (2021)

Machine Learning and Clinical-Radiological Characteristics for the Classification of Prostate Cancer in PI-RADS 3 Lesions
por: Gravina, Michela, et al.
Publicado: (2022)

The significance of equivocal bone findings in staging PSMA imaging in the preoperative setting: validation of the PSMA-RADS version 1.0
por: Kuten, Jonathan, et al.
Publicado: (2021)

Utility of multiple core biopsies during transperineal template-guided mapping biopsy for patients with large prostates and PI-RADS 1–2 on multiparametric magnetic resonance imaging
por: Lee, Chung Un, et al.
Publicado: (2022)

Prostate MRI based on PI-RADS version 2: how we review and report
por: Steiger, Philipp, et al.
Publicado: (2016)

PI-RADS 2.1 und strukturierte Befundung der Magnetresonanztomographie der Prostata
por: Hötker, Andreas, et al.
Publicado: (2021)

The Application of Biopsy Density in Transperineal Templated-Guided Biopsy Patients With PI-RADS<3
por: Zhu, Hai, et al.
Publicado: (2022)

A Framework of Analysis to Facilitate the Harmonization of Multicenter Radiomic Features in Prostate Cancer
por: Castaldo, Rossana, et al.
Publicado: (2022)

Utility of Clinical–Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions
por: Jin, Pengfei, et al.
Publicado: (2022)

Combining Multiparametric MRI Radiomics Signature With the Vesical Imaging-Reporting and Data System (VI-RADS) Score to Preoperatively Differentiate Muscle Invasion of Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2021)

Combining clinical and MRI data to manage PI-RADS 3 lesions and reduce excessive biopsy
por: Yang, Shuo, et al.
Publicado: (2020)

Value of an online PI-RADS v2.1 score calculator for assessment of prostate MRI
por: Barth, Borna K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fe496o6gl2qdb7oudc6gofghae